PAX8 and thyroid cancer: Bioinformatic analysis performed using the UCSC Xena platform (https://xena.ucsc.edu/compare-tissue/), based on data from the TCGA Thyroid Cancer (THCA) cohort and accessed on 28 March 2025, revealed that PAX8 expression does not significantly influence overall survival in thyroid carcinoma patients (Figure 2A).